TAILored Versus COnventional AntithRombotic StratEgy IntenDed for Complex HIgh-Risk PCI

NCT03465644 · clinicaltrials.gov ↗

PHASE4

Phase

COMPLETED

Status

2018

Enrollment

OTHER

Sponsor class

Conditions

Coronary Stenoses

Interventions

DRUG: Tailored antithrombotic strategy
DRUG: Conventional antithrombotic strategy

Sponsor

Duk-Woo Park, MD

Collaborators

[object Object]